This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
3u2c
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | [[Image:3u2c.png|left|200px]] | ||
| - | |||
{{STRUCTURE_3u2c| PDB=3u2c | SCENE= }} | {{STRUCTURE_3u2c| PDB=3u2c | SCENE= }} | ||
| - | |||
===Aldose reductase in complex with NSAID-type inhibitor at 1.0 A resolution=== | ===Aldose reductase in complex with NSAID-type inhibitor at 1.0 A resolution=== | ||
| + | ==Function== | ||
| + | [[http://www.uniprot.org/uniprot/ALDR_HUMAN ALDR_HUMAN]] Catalyzes the NADPH-dependent reduction of a wide variety of carbonyl-containing compounds to their corresponding alcohols with a broad range of catalytic efficiencies. | ||
==About this Structure== | ==About this Structure== | ||
| Line 13: | Line 12: | ||
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID:021997888</ref><references group="xtra"/> | + | <ref group="xtra">PMID:021997888</ref><references group="xtra"/><references/> |
[[Category: Aldehyde reductase]] | [[Category: Aldehyde reductase]] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
Revision as of 12:41, 3 July 2013
Contents |
Aldose reductase in complex with NSAID-type inhibitor at 1.0 A resolution
Function
[ALDR_HUMAN] Catalyzes the NADPH-dependent reduction of a wide variety of carbonyl-containing compounds to their corresponding alcohols with a broad range of catalytic efficiencies.
About this Structure
3u2c is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Steuber H. An Old NSAID Revisited: Crystal Structure of Aldose Reductase in Complex with Sulindac at 1.0 A Supports a Novel Mechanism for its Anticancer and Antiproliferative Effects. ChemMedChem. 2011 Oct 13. doi: 10.1002/cmdc.201100374. PMID:21997888 doi:10.1002/cmdc.201100374
